Post-stroke cognitive impairment: epidemiology, mechanisms and management

被引:511
作者
Sun, Jia-Hao [1 ]
Tan, Lan [1 ,2 ,3 ]
Yu, Jin-Tai [1 ,2 ,3 ]
机构
[1] Qingdao Univ, Qingdao Municipal Hosp, Sch Med, Dept Neurol, 5 Donghai Middle Rd, Qingdao 266071, Peoples R China
[2] Ocean Univ China, Coll Med & Pharmaceut, Qingdao 266003, Peoples R China
[3] Nanjing Med Univ, Qingdao Municipal Hosp, Dept Neurol, Nanjing 210000, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Post-stroke cognitive impairment; prevalence; risk factor; mechanism; treatment;
D O I
10.3978/j.issn.2305-5839.2014.08.05
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Post-stroke cognitive impairment occurs frequently in the patients with stroke. The prevalence of post-stroke cognitive impairment ranges from 20% to 80%, which varies for the difference between the countries, the races, and the diagnostic criteria. The risk of post-stroke cognitive impairment is related to both the demographic factors like age, education and occupation and vascular factors. The underlying mechanisms of post-stroke cognitive impairment are not known in detail. However, the neuroanatomical lesions caused by the stroke on strategic areas such as the hippocampus and the white matter lesions (WMLs), the cerebral microbleeds (CMBs) due to the small cerebrovascular diseases and the mixed AD with stroke, alone or in combination, contribute to the pathogenesis of post-stroke cognitive impairment. The treatment of post-stroke cognitive impairment may benefit not only from the anti-dementia drugs, but also the manage measures on cerebrovascular diseases. In this review, we will describe the epidemiological features and the mechanisms of post-stroke cognitive impairment, and discuss the promising management strategies for these patients.
引用
收藏
页数:16
相关论文
共 116 条
[1]   Long-Term Treatment with Citicoline May Improve Poststroke Vascular Cognitive Impairment [J].
Alvarez-Sabin, Jose ;
Ortega, Gemma ;
Jacas, Carlos ;
Santamarina, Estevo ;
Maisterra, Olga ;
Ribo, Marc ;
Molina, Carlos ;
Quintana, Manuel ;
Roman, Gustavo C. .
CEREBROVASCULAR DISEASES, 2013, 35 (02) :146-154
[2]   Citicoline in Vascular Cognitive Impairment and Vascular Dementia After Stroke [J].
Alvarez-Sabin, Jose ;
Roman, Gustavo C. .
STROKE, 2011, 42 (01) :S40-S43
[3]   Galantamine treatment of vascular dementia: A randomized trial [J].
Auchus, A. P. ;
Brashear, H. R. ;
Salloway, S. ;
Korczyn, A. D. ;
De Deyn, P. P. ;
Gassmann-Mayer, C. .
NEUROLOGY, 2007, 69 (05) :448-458
[4]   Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics [J].
Babu, Chidambaram Saravana ;
Ramanathan, Muthiah .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2011, 29 (01) :93-105
[5]  
Ballard C, 2008, CURR MED RES OPIN, V24, P2561, DOI [10.1185/03007990802328142, 10.1185/03007990802328142 ]
[6]   Pharmacological prevention and treatment of vascular dementia: Approaches and perspectives [J].
Baskys, Andrius ;
Cheng, Jin-xiang .
EXPERIMENTAL GERONTOLOGY, 2012, 47 (11) :887-891
[7]   Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease [J].
Benedictus, Marije R. ;
Goos, Jeroen D. C. ;
Binnewijzend, Maja A. A. ;
Muller, Majon ;
Barkhof, Frederik ;
Scheltens, Philip ;
Prins, Niels D. ;
van der Flier, Wiesje M. .
NEUROBIOLOGY OF AGING, 2013, 34 (11) :2488-2494
[8]   Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study [J].
Benisty, S. ;
Gouw, A. A. ;
Porcher, R. ;
Madureira, S. ;
Hernandez, K. ;
Poggesi, A. ;
van der Flier, W. M. ;
van Straaten, E. C. W. ;
Verdelho, A. ;
Ferro, J. ;
Pantoni, L. ;
Inzitari, D. ;
Barkhof, F. ;
Fazekas, F. ;
Chabriat, H. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (05) :478-483
[9]  
Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub3, 10.1002/14651858.CD001190.pub2]
[10]   Efficacy and tolerability of donepezil in vascular dementia -: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial [J].
Black, S ;
Román, GC ;
Geldmacher, DS ;
Salloway, S ;
Hecker, J ;
Burns, A ;
Perdomo, C ;
Kumar, D ;
Pratt, R .
STROKE, 2003, 34 (10) :2323-2330